Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAmrutanjan

    Amrutanjan

    Jump to

    • Amrutanjan to list products on Amazon

      While initiatives have been taken to strengthen distribution in the existing channels, e-commerce is also the principal area of focus for the company's management as part of Go to Market effort, Amrutanjan Health Care said in a filing to BSE.

    • Buy Amrutanjan; target of Rs 470: Firstcall Research

      Firstcall Research is bullish on Amrutanjan and has recommended buy rating on the stock with a target price of Rs 470 in its research report dated September 28, 2015.

    • Check out: Buzzing small cap stocks on September 17

      Here's how small cap stocks opened on September 17

    • Bull's Eye: Buy Aban Offshore, REC, HDIL; short VIP Ind

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Stocks in news: Gati, PFC, Amrutanjan, NTPC, Mphasis

      Karnataka Bank | Gati | PFC | Lanco Infratech | ADC India Communications | Woolite Mercantile | Panacea Biotech | Amrutanjan Healthcare | Axis Bank | NTPC and Mphasis are stocks, which are in the news today.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347